54 related articles for article (PubMed ID: 19011666)
1. Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies.
Savani BN; Koklanaris EK; Le Q; Shenoy A; Goodman S; Barrett AJ
Biol Blood Marrow Transplant; 2009 Mar; 15(3):377-81. PubMed ID: 19203730
[TBL] [Abstract][Full Text] [Related]
2. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Kooijmans EC; Bökenkamp A; Tjahjadi NS; Tettero JM; van Dulmen-den Broeder E; van der Pal HJ; Veening MA
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008944. PubMed ID: 30855726
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34
Kosuri S; Adrianzen Herrera D; Scordo M; Shah GL; Cho C; Devlin SM; Maloy MA; Nieves J; Borrill T; Carlow DC; Avecilla ST; Meagher RC; O'Reilly RJ; Papadopoulos EB; Jakubowski AA; Koehne G; Gyurkocza B; Castro-Malaspina H; Shaffer BC; Tamari R; Giralt SA; Perales MA
Biol Blood Marrow Transplant; 2017 Nov; 23(11):2004-2011. PubMed ID: 28733264
[TBL] [Abstract][Full Text] [Related]
4. Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia.
Shalabi H; Angiolillo A; Fry TJ
Front Pediatr; 2015; 3():80. PubMed ID: 26484338
[TBL] [Abstract][Full Text] [Related]
5. Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children.
Madden LM; Ngwube AI; Shenoy S; Druley TE; Hayashi RJ
J Pediatr Hematol Oncol; 2015 Mar; 37(2):e94-e101. PubMed ID: 25333837
[TBL] [Abstract][Full Text] [Related]
6. Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer.
Ethier MC; Regier DA; Tomlinson D; Judd P; Doyle J; Gassas A; Naqvi A; Sung L
Support Care Cancer; 2012 Aug; 20(8):1771-7. PubMed ID: 21947490
[TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the Oral Mucositis Daily Questionnaire for child self-report and importance of mucositis in children treated with chemotherapy.
Manji A; Tomlinson D; Ethier MC; Gassas A; Maloney AM; Sung L
Support Care Cancer; 2012 Jun; 20(6):1251-8. PubMed ID: 21681385
[TBL] [Abstract][Full Text] [Related]
8. Beyond steroids: A systematic review and proposed solutions to managing acute graft-versus-host disease in adolescents and young adults.
Friend BD; Schiller GJ
Blood Rev; 2022 Mar; 52():100886. PubMed ID: 34509319
[TBL] [Abstract][Full Text] [Related]
9. Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI.
Druley TE; Hayashi R; Mansur DB; Zhang QJ; Barnes Y; Trinkaus K; Witty S; Thomas T; Klein EE; DiPersio JF; Adkins D; Shenoy S
Bone Marrow Transplant; 2009 Feb; 43(4):307-14. PubMed ID: 19011666
[TBL] [Abstract][Full Text] [Related]
10. Single center experience with total body irradiation and melphalan (TBI-MEL) myeloablative conditioning regimen for allogeneic stem cell transplantation (SCT) in patients with refractory hematologic malignancies.
Bhatnagar B; Rapoport AP; Fang HB; Ilyas C; Marangoz D; Akbulut V; Ruehle K; Badros A; Yanovich S; Akpek G
Ann Hematol; 2014 Apr; 93(4):653-60. PubMed ID: 24097082
[TBL] [Abstract][Full Text] [Related]
11. Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation.
Nagler A; Or R; Naparstek E; Varadi G; Slavin S
Exp Hematol; 2000 Sep; 28(9):1096-104. PubMed ID: 11008023
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
van Besien K; Devine S; Wickrema A; Jessop E; Amin K; Yassine M; Maynard V; Stock W; Peace D; Ravandi F; Chen YH; Cheung T; Vijayakumar S; Hoffman R; Sosman J
Bone Marrow Transplant; 2003 Jul; 32(1):9-13. PubMed ID: 12815472
[TBL] [Abstract][Full Text] [Related]
14. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.
Belkacémi Y; Labopin M; Hennequin C; Hoffstetter S; Mungai R; Wygoda M; Lundell M; Finke J; Aktinson C; Lorchel F; Durdux C; Basara N
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):544-51. PubMed ID: 17141976
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
